Skip to content

1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane

C26H23Cl2F3N2O3 — CID 145417227

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane
SMILESC1CCC1.O=C1N(c2ccc(Cl)cc2)CC(O)(c2cccc(OC(F)(F)F)c2)N1c1ccc(Cl)cc1
InChIInChI=1S/C22H15Cl2F3N2O3.C4H8/c23-15-4-8-17(9-5-15)28-13-21(31,14-2-1-3-19(12-14)32-22(25,26)27)29(20(28)30)18-10-6-16(24)7-11-18;1-2-4-3-1/h1-12,31H,13H2;1-4H2
InChIKeyGVGGERRTKUMELU-UHFFFAOYSA-N
MW539.38 g/mol
LogP7.74
Rot. Bonds4

About 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane

1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane (PubChem CID 145417227) has the molecular formula C26H23Cl2F3N2O3 and a molecular weight of 539.38 g/mol. Its IUPAC name is 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane.

Molecular Properties

Compound Name1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane
PubChem CID145417227
Molecular FormulaC26H23Cl2F3N2O3
Molecular Weight539.38 g/mol
Exact Mass538.10
IUPAC Name1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane
SMILESC1CCC1.O=C1N(c2ccc(Cl)cc2)CC(O)(c2cccc(OC(F)(F)F)c2)N1c1ccc(Cl)cc1
InChIInChI=1S/C22H15Cl2F3N2O3.C4H8/c23-15-4-8-17(9-5-15)28-13-21(31,14-2-1-3-19(12-14)32-22(25,26)27)29(20(28)30)18-10-6-16(24)7-11-18;1-2-4-3-1/h1-12,31H,13H2;1-4H2
InChIKeyGVGGERRTKUMELU-UHFFFAOYSA-N
XLogP7.74
TPSA53.01 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms36
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500539.38
LogP ≤ 57.74
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane?
The IUPAC name of 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane (CID 145417227) is 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane.
What is the SMILES notation for 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane?
The canonical SMILES for 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane is C1CCC1.O=C1N(c2ccc(Cl)cc2)CC(O)(c2cccc(OC(F)(F)F)c2)N1c1ccc(Cl)cc1.
What is the InChIKey of 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane?
The InChIKey is GVGGERRTKUMELU-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H15Cl2F3N2O3.C4H8/c23-15-4-8-17(9-5-15)28-13-21(31,14-2-1-3-19(12-14)32-22(25,26)27)29(20(28)30)18-10-6-16(24)7-11-18;1-2-4-3-1/h1-12,31H,13H2;1-4H2.
What are the key properties of 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane?
1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane has a molecular weight of 539.38 g/mol, XLogP of 7.74, 4 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 1,3-bis(4-chlorophenyl)-4-hydroxy-4-[3-(trifluoromethoxy)phenyl]imidazolidin-2-one;cyclobutane is sourced from PubChem (CID 145417227), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.